NYSEAMERICAN : APUS
Apimeds Pharmaceuticals US, Inc. — Company profile
Healthcare · Drug Manufacturers - Specialty & Generic · United Arab Emirates
Last price 3.1 USD (Oct 30, 2026, 9:31 AM EDT) · Market cap 4.68M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.
Details
| Name | Apimeds Pharmaceuticals US, Inc. |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Founded | 2020 |
| Ipo Date | 2025-05-09 |
| Ceo | Vinod Menon |
| Country | United States |
| Exchange | NYSEAMERICAN |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 4.00 |
| Isin | US03771D2018 |
| Cusip | 03771D201 |
| Cik | 1894525 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Sungjoon Chae | Co-Chief Executive Officer and Director |
| Dr. Vinod Menon | Founder and Co-Chief Executive Officer |
| Erik C. Emerson | President |
| Eric Michael Sherb C.P.A. | Chief Financial Officer |
| Captain Sandeep Singh Yadav | Chief Operating Officer |
| Amardeep Singh | Chief Technology Officer |
Contact
| Address | 100 Matawan Rd, Suite 325, Matawan, New Jersey 07747, United States |
| Phone | 848 201 5010 |
| Website | https://www.mindwavedao.com |